AROMASIN 25 MG 30 TABS

INDICATION AROMASIN IS A PRESCRIPTION MEDICINE FOR: EARLY BREAST CANCER: AROMASIN IS INDICATED FOR THE ADJUVANT TREATMENT (ADDITIONAL TREATMENT GIVEN AFTER THE PRIMARY OR MAIN TREATMENT) OF POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE (ER POSITIVE) EARLY BREAST CANCER. TREATMENT WITH AROMASIN SHOULD BEGIN 2 TO 3 YEARS AFTER TAMOXIFEN AT WHICH TIME TAMOXIFEN SHOULD BE STOPPED. TREATMENT WITH AROMASIN SHOULD CONTINUE FOR 2 TO 3 YEARS UNTIL A TOTAL OF 5 YEARS OF ADJUVANT TREATMENT OF TAMOXIFEN AND AROMASIN HAVE BEEN COMPLETED. ADVANCED BREAST CANCER: AROMASIN IS INDICATED FOR THE TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WHOSE DISEASE HAS PROGRESSED AFTER TAMOXIFEN THERAPY. DOSE: ONE 25 MG TABLET ONCE DAILY AFTER A MEAL